Profiel
Xue Dan Wu is currently Chief Executive Officer & Executive Director at Pharmesis International Ltd. since 2017 and Chairman at Sichuan Longlife Pharmaceutical Co. Ltd. Mr. Wu was Chairman & General Manager at Chengdu Kinna Pharmaceutical Co. Ltd. Mr. Wu completed an undergraduate degree at Union University in 1987.
Actieve functies van Xue Dan Wu
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMESIS INTERNATIONAL LTD. | Algemeen Directeur | 31-12-2017 |
Sichuan Longlife Pharmaceutical Co., Ltd.
Sichuan Longlife Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Develops, manufactures and sells traditional Chinese medicines | Voorzitter | - |
Eerdere bekende functies van Xue Dan Wu
| Bedrijven | Functie | Einde |
|---|---|---|
Chengdu Kinna Pharmaceutical Co., Ltd.
Chengdu Kinna Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medicines & health tonic products | Algemeen Directeur | - |
Opleiding van Xue Dan Wu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Pharmesis International Ltd.
Pharmesis International Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in the manufacturing and distributing pharmaceutical products | Health Technology |
Union University
Union University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chengdu Kinna Pharmaceutical Co., Ltd.
Chengdu Kinna Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medicines & health tonic products | Health Technology |
Sichuan Longlife Pharmaceutical Co., Ltd.
Sichuan Longlife Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Develops, manufactures and sells traditional Chinese medicines | Health Technology |
















